Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Alopecia areata can cause unpredictable hair loss, and treatments like corticosteroids and minoxidil may help but have varying side effects.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

Some treatments can help hair regrowth in alopecia areata, but none offer a cure, and effectiveness varies.

Corticosteroids are the most effective treatment for Satoyoshi syndrome.

Some children with localized scleroderma are rarely resistant to methotrexate, and no common profile for resistance was found.

Various treatments exist for alopecia areata, but none are completely satisfactory; choice depends on age, disease extent, and preference.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.

Erosive pustular dermatosis of the scalp is a rare condition that causes scarring hair loss, mainly in older women, and requires ongoing treatment.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

Pregnancy can cause skin changes and affect existing skin conditions, with limited treatment options due to the need for fetal safety.

The document concludes that reactivation of herpesviruses, especially HHV-6, is linked to severe symptoms and complications in drug-induced hypersensitivity syndrome.

Corticosteroids are the most common treatment for alopecia areata, but many patients need better options.

The analysis aims to identify the most effective and safest treatments for alopecia areata.

Early and aggressive treatment of scarring alopecia is important to prevent further hair follicle damage.

Tofacitinib may work better than methotrexate for treating moderate-to-severe alopecia areata.

PCOS management involves medication, lifestyle changes, and personalized treatment to address symptoms and improve health.

A woman with skin and joint issues progressed from one type of lupus to another, highlighting the need to recognize complex conditions.

Chronic granulomatous disease may be linked to developing systemic lupus erythematosus.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Mixed Connective Tissue Disease can develop from overlapping symptoms of several autoimmune diseases, making diagnosis complex.

New treatments for child hair loss due to immune issues are effective but not yet officially approved.